|
|
Volumn 3, Issue 2, 2002, Pages 257-263
|
|
The application of genetics to the discovery of better medicines
|
|
Author keywords
Clinical trial; Disease association; Drug response; Drug target; Genetics; SNP
|
|
Indexed keywords
CHEMOKINE RECEPTOR CCR5;
DRUG;
GELATINASE B;
INTERLEUKIN 1;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
TUMOR NECROSIS FACTOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CORONARY ARTERY DISEASE;
DIAGNOSTIC VALUE;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG TARGETING;
ENVIRONMENTAL FACTOR;
EXPERIMENTATION;
FAMILY STUDY;
GENE DELETION;
GENE MUTATION;
GENE SEQUENCE;
GENETIC ANALYSIS;
GENETIC POLYMORPHISM;
GENETIC RISK;
GENOTYPE;
HEREDITY;
HETEROZYGOTE;
HUMAN;
HYPOTHESIS;
INFLAMMATION;
INSULIN RESISTANCE;
MEDICAL INFORMATION;
MEDICAL RESEARCH;
METHODOLOGY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT CARE;
PERIODONTITIS;
PHARMACOGENETICS;
PHENOTYPE;
PREDICTION;
PREVALENCE;
PUBLISHING;
RESTENOSIS;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SAMPLE SIZE;
SIDE EFFECT;
SINGLE NUCLEOTIDE POLYMORPHISM;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
GENETIC TECHNIQUES;
GENETICS, MEDICAL;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 0036124149
PISSN: 14622416
EISSN: None
Source Type: Journal
DOI: 10.1517/14622416.3.2.257 Document Type: Article |
|
Times cited : (18)
|
|
References (37)
|
